bluebird bio, Inc. Business Finance Contracts & Agreements

Fourth Amendment to Loan and Security Agreement, dated as of August 29, 2024, by and among the Company, the several banks and other financial institutions or entities party... (Filed With SEC on August 30, 2024)

Third Amendment to Loan and Security Agreement, dated as of August 13, 2024, by and among the Company, the several banks and other financial institutions or entities party... (Filed With SEC on August 14, 2024)

Form of Warrant Agreement Amendment (Filed With SEC on August 14, 2024)

Form of Warrant Agreement (Filed With SEC on August 14, 2024)

Second Amendment to Loan and Security Agreement, dated as of July 9, 2024, by and among the Company, the several banks and other financial institutions or entities party thereto,... (Filed With SEC on July 11, 2024)

First Amendment to Loan and Security Agreement, dated as of April 30, 2024, by and among the Company, the several banks and other financial institutions or entities party thereto,... (Filed With SEC on May 3, 2024)

Loan and Security Agreement, dated as of March 15, 2024, by and among the Company, the several banks and other financial institutions or entities party thereto, as lenders, and... (Filed With SEC on May 3, 2024)

Underwriting Agreement, dated as of December 19, 2023, by and among bluebird bio, Inc., Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC (Filed With SEC on December 20, 2023)

Invoice Purchase and Sale Agreement, dated as of December 14, 2023, by and between bluebird bio, Inc. and Alterna Capital Solutions LLC (Filed With SEC on December 18, 2023)

Asset Purchase Agreement, dated as of October 26, 2023, by and between bluebird bio, Inc. and Novartis Pharma AG (Filed With SEC on October 30, 2023)

Underwriting Agreement, dated as of January 18, 2023, by and among bluebird bio, Inc., Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC (Filed With SEC on January 19, 2023)

Asset Purchase Agreement, dated as of January 5, 2023, by and between bluebird bio, Inc. and Bristol-Myers Squibb Company (Filed With SEC on January 6, 2023)

Asset Purchase Agreement, dated as of November 29, 2022, by and between bluebird bio, Inc. and argenx BV (Filed With SEC on November 30, 2022)

Equity Distribution Agreement, dated as of June 22, 2022, by and between bluebird bio, Inc. and Goldman Sachs & Co. LLC (Filed With SEC on June 22, 2022)

Registration Rights Agreement, dated September 7, 2021, by and among the Registrant and the persons listed on the attached Schedule A thereto (Filed With SEC on November 5, 2021)

Securities Purchase Agreement, dated September 7, 2021, by and among the Registrant and the institutional investors named therein (Filed With SEC on November 5, 2021)

Registration Rights Agreement, dated September 7, 2021, by and between the Company and the persons listed on the attached Schedule A thereto (Filed With SEC on September 8, 2021)

Securities Purchase Agreement, dated September 7, 2021, by and among the Company and the institutional investors named therein (Filed With SEC on September 8, 2021)

Form of Pre-Funded Warrant (Filed With SEC on September 8, 2021)

First Amendment to Amended and Restated Co-Development, Co-Promote and Profit Share Agreement by and between the Registrant and Celgene Corporation and Celgene European Investment... (Filed With SEC on August 5, 2020)

Underwriting Agreement, dated as of May 18, 2020, among bluebird bio, Inc. and Goldman Sachs & Co. LLC, BofA Securities, Inc. and Cowen and Company, LLC, as representatives of the... (Filed With SEC on May 19, 2020)

Underwriting Agreement, dated as of July 24, 2018, among bluebird bio, Inc. and Goldman Sachs & Co. LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, J.P. Morgan Securities... (Filed With SEC on July 25, 2018)

First Amendment of the Bluebird Bio, Inc. 2013 Employee Stock Purchase Plan (Filed With SEC on February 21, 2018)

Underwriting Agreement, dated as of December 12, 2017, among bluebird bio, Inc. and Goldman Sachs & Co. LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, J.P. Morgan... (Filed With SEC on December 13, 2017)

BLUEBIRDBIO, INC. 3,810,000 Shares of Common Stock, par value $0.01 per share Underwriting Agreement (Filed With SEC on June 28, 2017)

BLUEBIRDBIO, INC. 3,289,473 Shares of Common Stock, par value $0.01 per share Underwriting Agreement (Filed With SEC on December 7, 2016)

CONSENT TO ASSIGNMENT (Filed With SEC on November 2, 2016)

BLUEBIRD BIO, INC. 2,941,176Shares of Common Stock, par value $0.01 per share Underwriting Agreement (Filed With SEC on June 24, 2015)

BLUEBIRD BIO, INC. 2,650,000Shares of Common Stock, par value $0.01 per share Underwriting Agreement (Filed With SEC on December 16, 2014)

Amendment to the Amended & Restated Investors Rights Agreement (Filed With SEC on August 12, 2014)

BLUEBIRD BIO, INC. 3,000,000Shares of Common Stock, par value $0.01 per share Underwriting Agreement (Filed With SEC on July 9, 2014)

STOCK PURCHASE AGREEMENT BY AND AMONG BLUEBIRD BIO, INC., PRECISION GENOME ENGINEERING, INC., DR. ANDREW SCHARENBERG, M.D., AS REPRESENTATIVE, AND THE OTHER PERSONSLISTED ON THE... (Filed With SEC on June 30, 2014)

BLUEBIRD BIO, INC. 2013 EMPLOYEESTOCK PURCHASE PLAN (Filed With SEC on June 4, 2013)

BLUEBIRD BIO, INC. [] Sharesof Common Stock, par value $0.01 per share Underwriting Agreement (Filed With SEC on June 4, 2013)

BLUEBIRD BIO, INC. FOURTH AMENDMENT TO THE 2010 STOCK OPTION AND GRANT PLAN (Filed With SEC on May 14, 2013)

AMENDMENT TO THE GENETIX PHARMACEUTICALS INC. 2002 EMPLOYEE, DIRECTORAND CONSULTANT STOCK PLAN (Filed With SEC on May 14, 2013)

FORM OF SERIES B PREFERRED WARRANT (Filed With SEC on May 14, 2013)

FORM OF SERIES A-1 PREFERRED WARRANT (Filed With SEC on May 14, 2013)

FORM OF COMMON STOCK WARRANT (Filed With SEC on May 14, 2013)

Category

Industry

Companies

Contracts

bluebird bio, Inc. Business Finance Contracts & Agreements